NEXGEL, INC. Interest Expense Nonoperating
NEXGEL, INC. (NXGL) reported Interest Expense Nonoperating of $34.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-31
- NEXGEL, INC. interest expense nonoperating for the quarter ending 2024-12-31 was $14.00K, a 600.00% increase year-over-year.
- NEXGEL, INC. interest expense nonoperating for the quarter ending 2024-09-30 was $20.00K, a 566.67% increase year-over-year.
- NEXGEL, INC. interest expense nonoperating for the quarter ending 2024-06-30 was $30.00K, a 233.33% increase year-over-year.
- NEXGEL, INC. interest expense nonoperating for the quarter ending 2023-12-31 was $2.00K.
- NEXGEL, INC. interest expense nonoperating for fiscal 2025 was $34.00K, a 58.02% decline from fiscal 2024.
- NEXGEL, INC. interest expense nonoperating for fiscal 2024 was $81.00K, a 440.00% increase from fiscal 2023.
- NEXGEL, INC. interest expense nonoperating for fiscal 2023 was $15.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $34.00K 10-K · filed 2026-03-31 | |||
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $34.00K derived: sum of 2 quarters · filed 2026-03-31 | $64.00K derived: sum of 3 quarters · filed 2026-03-31 | $81.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $20.00K 10-Q · filed 2024-11-13 | $50.00K derived: sum of 2 quarters · filed 2024-11-13 | $67.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $30.00K 10-Q · filed 2024-08-19 | $46.00K 10-Q · filed 2024-08-19 | ||
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $5.00K derived: sum of 2 quarters · filed 2025-03-27 | $14.00K derived: sum of 3 quarters · filed 2025-03-27 | $15.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $3.00K 10-Q · filed 2024-11-13 | $12.00K derived: sum of 2 quarters · filed 2024-11-13 | $13.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $9.00K 10-Q · filed 2024-08-19 | $10.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |